Marshall Islands vs Norway: Previously treated cases tested for RR-/MDR-TB
Marshall Islands
100.0%
in 2024
Norway
100.0%
in 2024
Marshall Islands rank
1st
Norway rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Marshall Islands
- Norway
How they compare
Marshall Islands currently reports 100.0% against 100.0% in Norway, a difference of 0.0%.
The two have swapped places 7 times across 19 shared years of data; in 2005 it was Marshall Islands ahead.
Marshall Islands ranks 1st and Norway ranks 1st of 180 countries.
Across the 3 decades both report, Marshall Islands averaged higher in 1 and Norway in 2.
Head to head by decade
| Decade | Marshall Islands | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 54.5% | 62.0% | 7.5% | Norway |
| 2010s | 40.9% | 62.5% | 21.6% | Norway |
| 2020s | 100.0% | 89.4% | 10.6% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Marshall Islands or Norway?
- Marshall Islands, at 100.0% against 100.0% in Norway as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Marshall Islands and Norway?
- 0.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Norway?
- 19 years are reported by both, from 2005 to 2024.
- How do Marshall Islands and Norway rank globally for previously treated cases tested for rr-/mdr-tb?
- Marshall Islands ranks 1st and Norway ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.